Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-kappaB and Smad2/3 Signaling.

Article Details

Citation

Chen YM, Chiang WC, Yang Y, Lai CF, Wu KD, Lin SL

Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-kappaB and Smad2/3 Signaling.

Mol Med. 2015 Apr 13;21:276-84. doi: 10.2119/molmed.2015.00023.

PubMed ID
25879629 [ View in PubMed
]
Abstract

Anti-Thy1 glomerulonephritis is a rat nephritis model closely simulating human mesangial proliferative glomerulonephritis. It affects primarily the mesangium, yet displays substantial proteinuria during the course. This study investigated the molecular signals underlying proteinuria in this disease and the modulation of which by the known antiproteinuric agent, pentoxifylline. Male Wistar rats were randomly divided into a control group and nephritic groups with or without treatment with IMD-0354 (an IkappaB kinase inhibitor), SB431542 (an activin receptor-like kinase inhibitor) or pentoxifylline. Kidney sections were prepared for histological examinations. Glomeruli were isolated for mRNA and protein analysis. Urine samples were collected for protein and nephrin quantitation. One day after nephritis induction, proteinuria developed together with ultrastructural changes of the podocyte and downregulation of podocyte mRNA and protein expression. These were associated with upregulation of tumor necrosis factor (TNF)-alpha and transforming growth factor (TGF)-beta/activins mRNAs and activation of nuclear factor (NF)-kappaB p65 and Smad2/3. IMD-0354 attenuated proteinuria on d 1, whereas SB431542 decreased proteinuria on d 3 and 5, in association with partial restoration of downregulated podocyte mRNA and protein expression. Pentoxifylline attenuated proteinuria and nephrinuria through the course, plus inhibition of p-NF-kappaB p65 (d 1) and p-Smad2/3 (d 5) and partial reversal of downregulated podocyte mRNA and protein. Our data show that the pathogenesis of proteinuria in anti-Thy1 glomerulonephritis involves TNF-alpha and TGF-beta/activin pathways, and the evolution of this process can be attenuated by pentoxifylline via downregulation of NF-kappaB and Smad signals and restoration of the podocyte component of the glomerular filtration barrier.

DrugBank Data that Cites this Article

Drugs